DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Kohli A, Kapoor R, Sims Z. et al.
Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study.
The Lancet Infectious diseases 2015;
15: 1049-1054
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.